Brief: Engene Reports Full Year 2024 Financial Results And Provides A Business Update
19/12/2024 21:24
Dec 19 (Reuters) - enGene Holdings Inc ENGN.O :
* ENGENE REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND
PROVIDES A
BUSINESS UPDATE
* ENGENE HOLDINGS: BLA FILING FOR DETALIMOGENE IN
BCG-UNRESPONSIVE
NMIBC WITH CIS ON TRACK FOR MID-2026
* ENGENE HOLDINGS: ADDITIONAL PRELIMINARY DATA FROM PIVOTAL
COHORT ANTICIPATED IN 2H 2025
Source text: ID:nBw3gzMkBa
Further company coverage: ENGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on enGene Therapeutics
See all newsBrief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
enGene Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026
Brief: Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares
Brief: enGene Reports First Quarter 2026 Financial Results and Provides Business Update